People of color face higher risk of flu hospitalization as U.S. faces potentially severe season, CDC says

People of color face higher risk of flu hospitalization as U.S. faces potentially severe season, CDC says


People of color are hospitalized with the flu at far higher rates than white Americans, according to a large multi-year study from the Centers for Disease Control and Prevention.

The CDC study, published Tuesday, looked at flu hospitalizations among adults from 2009 through last year using data from its flu surveillance network that includes more than 70 counties across 14 states.

Hospitalizations were 80% higher among Black adults than white adults, 30% higher among Native Americans, and 20% among higher among Hispanics, according to the CDC data.

Vaccination rates were lower among people of color than white adults. During last year’s flu season, vaccination coverage among white adults was 54% compared with 38% among Hispanics, 41% among Native Americans and 42% among Black adults.

CDC officials, in a call with reporters Tuesday, said lower vaccination rates among people of color are due to poorer access to healthcare, distrust of physicians and the government due to historical discrimination, and missed opportunities to get people immunized when they do go to the doctor.

People of color also often face poorer and more crowded housing conditions and more chronic illnesses which makes hospitalization from the flu more likely, officials said.

Prior to the Covid-19 pandemic, influenza was one of the most challenging respiratory diseases that hospitals faced every year. Flu seasons vary in their severity depending on the strain of the virus and the efficacy of the vaccines. Over the past decade, 9 million to 41 million people fell ill every year, 140,000 to 170,000 individuals were hospitalized and 12,000 to 52,000 died annually, according to CDC data.

Carla Black, a CDC epidemiologist, told reporters on Tuesday that flu is difficult to forecast, but the U.S. could be facing one of the worst seasons since the Covid pandemic began more than two years ago.

“We’ve had two mild flu seasons and this means we might be ripe for a severe season because people aren’t taking all the measures they took for Covid which also had an impact on the flu,” Black said. “People haven’t had natural disease in two years so there’s less natural immunity out there.”

Only 49% of eligible adults got their flu vaccine last year. Black said everyone ages 6 months and older should get their shot, but the CDC views a flu vaccination rate of 70% as a success.

The effectiveness of flu shots varies from year to year, though they are usually 40% to 60% effective at preventing illness, Black said. “Even people who do get sick are less likely to have severe outcomes like hospitalization and death,” she said.

Dr. Ashish Jha, the White House Covid taskforce leader, has called for all Americans who are eligible to get both their Covid omicron booster as well as their flu shot as soon as possible.

“What happens in the weeks and months ahead will have a large impact on how the winter goes and really what happens this winter is largely up to us as the American people,” Jha told reporters last week.

“Don’t wait — get your new flu shot and your new Covid shot today. If Americans did that we could save hundreds of lives each day this winter,” he said.



Source

How twin sister triathletes doubled down on sports success to raise health-startup millions from investors
Health

How twin sister triathletes doubled down on sports success to raise health-startup millions from investors

During their last year of completing work for doctoral degrees in physiology, twin sisters Michal Mor and Merav Mor started to compete in Ironman triathlon races. The demand for peak fitness led them to the realize the importance of understanding personal metabolism, and the lack of data being collected on it through devices accessible to […]

Read More
It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech
Health

It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech

Two graduate students research chemical products in a laboratory in Xiwangzhuang Town, Zaozhuang City, Shandong province of China, on Dec. 26, 2023. Nurphoto | Nurphoto | Getty Images BEIJING — For all the attention on U.S.-China competition in artificial intelligence, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development. […]

Read More
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
Health

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I’m back in New […]

Read More